|
Session Title: Monitoring and Evaluation Strategies to Improve National Human Immunodeficiency Virus (HIV) Prevention Programs
|
|
Panel Session 281 to be held in Room 102 in the Convention Center on Thursday, Nov 6, 10:55 AM to 12:25 PM
|
|
Sponsored by the Health Evaluation TIG
|
| Chair(s): |
| Dale Stratford,
Centers for Disease Control and Prevention,
bstratford@cdc.gov
|
| Abstract:
National health promotion and disease prevention programs require comprehensive monitoring and evaluation (M&E) plans to ensure quality service delivery, assess progress towards goals and objectives, and promote accountability. The Centers for Disease Control and Prevention (CDC) has implemented a multi-method M&E strategy to strengthen the Counseling, Testing, and Referral (CTR) component of CDC's national HIV prevention program. This session describes methods used to implement three HIV prevention M&E activities, and their applicability to other national programs: 1) development of quality assurance standards aimed at improving CTR data collection, management, and reporting; 2) use of national HIV prevention program performance indicators for monitoring progress in achieving CTR goals and objectives, and; 3) assessment of the impact of CDC's new recommendations for routine HIV testing in health care settings. Lessons learned about the collection, reporting, and utilization of M&E data for program improvement will be highlighted.
|
|
Program and Data Quality Assessment and Standards for HIV Counseling, Testing and Referral (PADQUA): Implications for Centers for Disease Control's National HIV Prevention Monitoring and Evaluation Efforts
|
| Renee Stein,
Centers for Disease Control and Prevention,
rstein1@cdc.gov
|
| Denise Duran,
Centers for Disease Control and Prevention,
dduran@cdc.gov
|
| Jane Mezoff,
Centers for Disease Control and Prevention,
jmezoff@cdc.gov
|
| Frances Belcher,
Macro International Inc,
frances.e.belcher@macrointernational.com
|
|
As part of the Division of HIV / AIDS Prevention's (DHAP) national monitoring and evaluation plan, client and test-level data are required to be collected at CDC-supported HIV Counseling, Testing and Referral (CTR) sites to describe the population receiving CTR services and to inform HIV prevention planning. CTR data are submitted by service providers to health departments where they are cleaned and analyzed for state-level reporting and prepared for submission to CDC for national-level analysis and reporting. Each step in the multi-level CTR data life cycle introduces the opportunity for data error and would benefit from the implementation of national quality assurance standards and monitoring procedures. This session will provide an overview of PADQUA, a project initiated by DHAP's Program Evaluation Branch to support the national investment in high quality monitoring data by developing and piloting a set of national data quality assurance standards for CTR data.
|
|
|
Using Performance Indicators to Monitor National HIV Prevention Programs
|
| Barbara Maciak,
Centers for Disease Control and Prevention,
bmaciak@cdc.gov
|
| Tamara Lamia,
Macro International Inc,
tamara.l.lamia@macrointernational.com
|
| David Cotton,
Macro International Inc,
david.a.cotton@macrointernational.com
|
| Pankaja Panda,
Centers for Disease Control and Prevention,
ppanda@cdc.gov
|
| Marla Vaughan,
Centers for Disease Control and Prevention,
mvaughan@cdc.gov
|
| Dale Stratford,
Centers for Disease Control and Prevention,
bstratford@cdc.gov
|
|
Performance indicators provide an important tool for monitoring national prevention programs, improving service delivery, and ensuring accountability. In 2003, the CDC's Division of HIV/AIDS Prevention (DHAP) developed National HIV Prevention Program Performance Indicators addressing program objectives and desired outcomes in critical areas of HIV prevention planning, service delivery, and evaluation. Since 2003, fifty-nine CDC-funded health department jurisdictions have submitted baseline, annual target, and five-year goal measures for each of 23 performance indicators. This presentation describes CDC's rationale for developing HIV prevention performance indicators; strategies for engaging stakeholders in indicator development and implementation; lessons learned regarding indicator data collection, calculation, and reporting, and; the utility of indicator data in the context of a national monitoring and evaluation plan. Sample indicators, calculation methods, and implementation challenges are presented for Counseling, Testing, and Referral (CTR).
| |
|
Evaluating the National Health Policy of Routine HIV Testing in Health-care Settings in the United States
|
| Denise Duran,
Centers for Disease Control and Prevention,
dduran@cdc.gov
|
| Renee Stein,
Centers for Disease Control and Prevention,
rstein1@cdc.gov
|
| Frances Belcher,
Centers for Disease Control and Prevention,
frances.e.belcher@macrointernational.com
|
| John Beltrami,
Centers for Disease Control and Prevention,
jbeltrami@cdc.gov
|
| Dale Stratford,
Centers for Disease Control and Prevention,
bsratford@cdc.gov
|
|
In 2006, the Centers for Disease Control and Prevention (CDC) released the revised HIV testing recommendations for private and public health-care providers in U.S. health-care settings. In 2007, a new program announcement (PA) funded 23 health departments to expand and integrate HIV testing in clinical settings for populations disproportionately affected by HIV. Short-term and long-term outcomes of the CDC recommendations and objectives of the PA include increasing the number of people diagnosed with HIV that are unaware of their infection and decreasing HIV morbidity and mortality, respectively. The Assessment of HIV Testing in Clinical Settings (AHITS) is a multi-methods evaluation project focusing on estimating the baseline of HIV testing prior to the release of the CDC recommendations and assessing challenges, strategies, and successes of grantees funded under the PA. AHITS includes process and outcome evaluation methods, and uses population-based surveys and in-depth interviews.
| |